Clinical Trials and Case Reports

To fully appreciate the complexity and challenges in interpreting hypertension trials, it is informative to review their evolution. The prospective, randomized, clinical trial has been the foundation for evaluating the effectiveness of blood pressure-lowering drugs. The duration of clinical trials rarely exceeds five years, and trials focus on so-called “hard end points”—notably, all-cause mortality and/or cause specific morbidity and mortality due to CVD, usually coronary heart disease (CHD) and/or stroke, but more recently heart failure (HF) as well.

The early clinical trials had the advantage of being able to compare “active therapy” with placebo and usually included patients with more severe hypertension, as compared with modern trials. Consequently, they generated more end points and had sufficient power to be conducted on a smaller scale than modern trials high blood pressure is often called a "silent disease" because people usually don't know they have it; there may be no outward symptoms or a sign, so monitoring the blood pressure is critical. Treating high blood pressure can take a multi-pronged approach including diet changes, medication, and exercise. Hypertension treatment comes in many forms -- from lifestyle changes to medication.

  • Integrating lifestyle advice into clinical management
  • Clinical practice guidelines for the management of overweight and obesity
  • Data management and statistical analysis and data validation processes
  • Meta-analysis of blood pressure-lowering drug trials
  • Reporting blood pressure parameters in clinical trails
  • Surrogate or intermediate disease markers
  • Assessment of overall cardiovascular risk in hypertensive patients
  • Primary biliary cirrhosis

Related Conference of Clinical Trials and Case Reports

November 02-03, 2017

3rd Global Summit on Heart Diseases

Bangkok, Thailand
December 11-12, 2017

22nd World Cardiology Conference

Rome, Italy
February 19-21, 2018

23rd European Heart Disease and Heart Failure Congress

Paris, France
19-20 March ,2018

23rd World Cardiology Conference

Hong Kong
April 19-20, 2018

3rd World Heart Congress

Amsterdam, Netherlands
May 14-16, 2018

2nd World Heart Congress

Tokyo, Japan
June 11-13, 2018

24th Annual Cardiologists Conference

Barcelona, Spain
July 11-12, 2018

International Conference on Cardiovascular Imaging

Sydney,Australia
July 18-19, 2018

25th Annual Cardiology Conference

Atlanta, USA
September 10-12, 2018

4th International Conference on Hypertension & Healthcare

Zurich, Switzerland
September 17-19,2018

25th Annual Cardiologists Conference

Tin Shui Wai,Hong Kong
October 17-18, 2018

Global Cardiology Summit

Seoul, South Korea

Clinical Trials and Case Reports Conference Speakers

Recommended Sessions

Related Journals

Are you interested in